Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 4
1999 4
2000 6
2001 2
2002 2
2004 5
2005 3
2006 6
2007 3
2008 5
2009 5
2010 8
2011 3
2012 5
2013 3
2014 5
2015 4
2016 1
2017 1
2019 3
2021 2
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Pelvic masses.
Barney SP, Muller CY, Bradshaw KD. Barney SP, et al. Among authors: muller cy. Med Clin North Am. 2008 Sep;92(5):1143-61, xi. doi: 10.1016/j.mcna.2008.04.007. Med Clin North Am. 2008. PMID: 18721656 Review.
Dual Actions of Ketorolac in Metastatic Ovarian Cancer.
Hudson LG, Cook LS, Grimes MM, Muller CY, Adams SF, Wandinger-Ness A. Hudson LG, et al. Among authors: muller cy. Cancers (Basel). 2019 Jul 24;11(8):1049. doi: 10.3390/cancers11081049. Cancers (Basel). 2019. PMID: 31344967 Free PMC article. Review.
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
Slomovitz BM, Filiaci VL, Walker JL, Taub MC, Finkelstein KA, Moroney JW, Fleury AC, Muller CY, Holman LL, Copeland LJ, Miller DS, Coleman RL. Slomovitz BM, et al. Among authors: muller cy. Gynecol Oncol. 2022 Mar;164(3):481-491. doi: 10.1016/j.ygyno.2021.12.031. Epub 2022 Jan 19. Gynecol Oncol. 2022. PMID: 35063278 Clinical Trial.
Cervical neoplasia complicating pregnancy.
Muller CY, Smith HO. Muller CY, et al. Obstet Gynecol Clin North Am. 2005 Dec;32(4):533-46. doi: 10.1016/j.ogc.2005.08.007. Obstet Gynecol Clin North Am. 2005. PMID: 16310670 Review.
Drug Repurposing from an Academic Perspective.
Oprea TI, Bauman JE, Bologa CG, Buranda T, Chigaev A, Edwards BS, Jarvik JW, Gresham HD, Haynes MK, Hjelle B, Hromas R, Hudson L, Mackenzie DA, Muller CY, Reed JC, Simons PC, Smagley Y, Strouse J, Surviladze Z, Thompson T, Ursu O, Waller A, Wandinger-Ness A, Winter SS, Wu Y, Young SM, Larson RS, Willman C, Sklar LA. Oprea TI, et al. Among authors: muller cy. Drug Discov Today Ther Strateg. 2011 Winter;8(3-4):61-69. doi: 10.1016/j.ddstr.2011.10.002. Drug Discov Today Ther Strateg. 2011. PMID: 22368688 Free PMC article.
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial.
Liu JF, Brady MF, Matulonis UA, Miller A, Kohn EC, Swisher EM, Cella D, Tew WP, Cloven NG, Muller CY, Bender DP, Moore RG, Michelin DP, Waggoner SE, Geller MA, Fujiwara K, D'Andre SD, Carney M, Alvarez Secord A, Moxley KM, Bookman MA. Liu JF, et al. Among authors: muller cy. J Clin Oncol. 2022 Jul 1;40(19):2138-2147. doi: 10.1200/JCO.21.02011. Epub 2022 Mar 15. J Clin Oncol. 2022. PMID: 35290101 Free PMC article. Clinical Trial.
Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259).
Donovan HS, Sereika SM, Wenzel LB, Edwards RP, Knapp JE, Hughes SH, Roberge MC, Thomas TH, Klein SJ, Spring MB, Nolte S, Landrum LM, Casey AC, Mutch DG, DeBernardo RL, Muller CY, Sullivan SA, Ward SE. Donovan HS, et al. Among authors: muller cy. J Clin Oncol. 2022 May 1;40(13):1464-1473. doi: 10.1200/JCO.21.00656. Epub 2022 Feb 7. J Clin Oncol. 2022. PMID: 35130043 Free PMC article. Clinical Trial.
73 results